Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.
The current price of MDT is $80.38 USD — it has increased by +0.22% in the past 24 hours. Watch Medtronic stock price performance more closely on the chart.
What is Medtronic stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Medtronic stocks are traded under the ticker MDT.
Is Medtronic stock price growing?▼
MDT stock has fallen by -1.95% compared to the previous week, the month change is a +5.55% rise, over the last year Medtronic has showed a -8.58% decrease.
What is Medtronic market cap?▼
Today Medtronic has the market capitalization of 103.2B
When is the next Medtronic earnings date?▼
Medtronic is going to release the next earnings report on August 25, 2026.
What were Medtronic earnings last quarter?▼
MDT earnings for the last quarter are 1.55 USD per share, whereas the estimation was 1.54 USD resulting in a +0.64% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Medtronic revenue for the last year?▼
Medtronic revenue for the last year amounts to 67.07B USD.
What is Medtronic net income for the last year?▼
MDT net income for the last year is 9.32B USD.
Does Medtronic pay dividends?▼
Yes, MDT dividends are paid quarterly. The last dividend per share was 0.71 USD. As of today, Dividend Yield (FWD)% is 3.58%.
How many employees does Medtronic have?▼
As of June 16, 2026, the company has 95,000 employees.
In which sector is Medtronic located?▼
Medtronic operates in the Health & Wellness sector.
When did Medtronic complete a stock split?▼
Medtronic has not had any recent stock splits.
Where is Medtronic headquartered?▼
Medtronic is headquartered in Galway, United States.